KandrotasRJGalPDouglasJBGroceJBIII. Rapid determination of maintenance heparin infusion rates with the use of non—steady-state heparin concentrations. Ann Pharmacother1993; 27: 1429–33.
2.
MungallDRAnbeDForresterPLLuomaTGenoveseRMahanJ. A prospective randomized comparison of computer-assisted versus GUSTO nomogram—directed heparin therapy. Clin Pharmacol Ther1994; 55: 591–6.
3.
MungallDRaskobGColemanRRosenbloomDLuddenTHullR. Pharmacokinetics and dynamics of heparin in patients with proximal vein thrombosis. J Clin Pharmacol1989; 29: 896–900.
4.
De SwartCANijmeyerBRoelofsTMSixmaJJ. Kinetics of intravenously administered heparin in normal humans. Blood1982; 60: 1251–8.
5.
HullRDRaskobGEHirshJJayRMLeclercJRGeertsWH. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med1986; 315: 1109–14.
6.
HirshJDalenJEDeykinDPollerL. Heparin: Mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. Chest1992; 102: 3365–75.
7.
KershawBWhiteRHMungallDVan HoutenJBrettfeldS. Computer assisted dosing of heparin: Management using a pharmacy based system. Arch Intern Med1994; 154: 1005–11.
8.
MungallDFloydR. Bayesian forecasting of APTT response to continuously infused heparin with and without warfarin administration. J Clin Pharmacol1989; 29: 1043–7.
